Halozyme
HALO
128 hedge funds and large institutions have $857M invested in Halozyme in 2014 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 39 reducing their positions, and 24 closing their positions.
41% more call options, than puts
Call options by funds: $13.5M | Put options by funds: $9.58M
36% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 39
8% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 24
2% less funds holding
Funds holding: 131 → 128 (-3)
22% less capital invested
Capital invested by funds: $1.1B → $857M (-$243M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$25.2M |
| 2 |
First Eagle Investment Management
New York
|
+$11.5M |
| 3 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$11.5M |
| 4 |
JCG
JHL Capital Group
Chicago,
Illinois
|
+$9.33M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$8.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$42.1M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$24.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.5M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$8.32M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$8.19M |
HALO Hedge Fund Activity: Q2 2014 in Review
128 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q2 2014, worth a combined $857M — down 22% from $1.1B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of HALO and 22 opened new positions — a net loss of 2 holders — while 39 trimmed existing stakes and 53 added.
The largest buyer was Iridian Asset Management, adding an estimated $25.2M. The largest seller was Franklin Resources, exiting entirely with an estimated $42.1M sold.
- 128 institutional investors held Halozyme (HALO) as of Q2 2014, down from 131 in Q1 2014.
- Funds reported $857M of Halozyme stock for Q2 2014, down 22% quarter-over-quarter.
- 22 funds opened new Halozyme positions in Q2 2014 and 24 closed out, a net change of -2 holders.
- The largest Halozyme buyer in Q2 2014 was Iridian Asset Management, an estimated $25.2M added.
- The largest Halozyme seller in Q2 2014 was Franklin Resources, an estimated $42.1M sold.
Based on aggregated 13F filings for Q2 2014.